Similar to our result, a high expression level of the OAS3 is detected in muscle biopsy of DM patients according to Musumeci’s study in 2018.They concluded that the activation of IFN pathway could result in the upregulation of OAS3. The gene discussed is IFNA1; the disease is dermatomyositis.